Bone health and laboratorial correlations of Vitamin D in Parkinson’s disease
Objective: To evaluate the correlation between levels of 25 (OH)D (Vitamin D) and Bone Mineral Density (BMD) in a parkinsonian population. Background: Considering a limiting…Tau and α-synuclein autoantibodies as potential biomarkers for Parkinson’s and Alzheimer’s diseases
Objective: To investigate the value of the naturally occurring serum AIAs of α-synuclein (α-syn) and tau, proteins as potential biomarker for diagnosis of PD in…Partial depletion of peripheral M1 macrophages ameliorates the neuroinflammation and dopaminergic neuronal death in the brain of a MPTP-induced mouse model of PD
Objective: Neuroinflammation in the PD brain involves the activation of microglia and the increasing levels of inflammatory cytokines. Several studies have shown that the peripheral…Dietary habits, motor and cognitive impairment in Parkinson’s Disease
Objective: To evaluate the relationship between dietary habits, motor and cognitive impairment in Parkinson's disease patients with both cross-sectional and longitudinal design Background: Diet and…Examining Parkinson’s disease psychosis treatment outcomes in the real world: The insyte observational study
Objective: The INSYTE Study–seeks to gain a better understanding of the management of PDP. INSYTE will describe the relative safety and effectiveness of various antipsychotic…Validation of a One-Page Impulse Control Disorder Questionnaire in a Parkinson’s Disease Clinic
Objective: We seek to report data on ICD symptoms collected on 120 patients with Parkinsonism attending specialist movement disorder outpatient clinics using a newly devised,…The Inter-rater Reliability of Parkinson’s Disease Sleep Scale 2 Indonesian Version
Objective: The objective is to create reliable version of Parkinson’s Disease Sleep Scale 2 in Indonesian language. Background: Sleep disorder is one of the most…PASSPORT, An Ongoing Phase 2 Study in Patients with PSP– Baseline Characteristics
Objective: To describe baseline characteristics of the participants with progressive supranuclear palsy (PSP) enrolled in the ongoing PASSPORT (NCT03068468) phase 2 study. Background: PSP is…The FOsmetpantotenate Replacement Therapy (FORT) Pivotal Trial: Utilization of a Novel Primary Efficacy Outcome in Patients with Pantothenate Kinase-Associated Neurodegeneration
Objective: To describe the methodology and novel primary efficacy outcome measure in the ongoing pivotal FORT trial in patients with pantothenate kinase-associated neurodegeneration (PKAN). Background:…Development of evidence-based clinical practice guideline (CPG) of complementary and alternative medicine (CAM) for Parkinson’s disease (PD)
Objective: The purpose of this CPG was to describe the state of evidence on CAM interventions for PD reflecting current clinical practice. Background: Many patients…
- « Previous Page
- 1
- …
- 154
- 155
- 156
- 157
- 158
- …
- 177
- Next Page »